ongo
worldwid
coronaviru
diseas
pandem
caus
sever
acut
respiratori
syndrom
coronaviru
present
confirmatori
diagnosi
revers
transcript
polymeras
chain
reaction
rtpcr
typic
take
sever
hour
requir
molecular
laboratori
perform
urgent
need
rapid
simplifi
costeffect
detect
method
develop
analyt
valid
protocol
direct
rapid
extractionfre
pcr
directpcr
detect
without
need
nucleic
acid
purif
rna
copi
per
reaction
viral
nucleocapsid
n
gene
respiratori
sampl
sputum
nasal
exud
detect
directli
use
onestep
inhibitorresist
assay
perform
assay
valid
commerci
avail
portabl
pcr
thermocycl
viral
lysi
revers
transcript
amplif
detect
achiev
singletub
homogen
reaction
within
minut
minim
handson
time
reduc
turnaroundtim
sampletoresult
obviat
need
rna
purif
reagent
could
enabl
wider
use
test
diagnosi
screen
research
countri
region
laboratori
capabl
limit
novel
coronaviru
diseas
caus
sever
acut
respiratori
syndrom
coronaviru
report
wuhan
china
decemb
world
health
organ
declar
pandem
trigger
variou
travel
restrict
border
control
contact
trace
quarantin
social
distanc
measur
mani
countri
despit
intervent
continu
spread
million
case
report
global
even
countri
welldevelop
public
health
system
aggress
implement
measur
instanc
singapor
report
first
import
case
rd
jan
first
local
transmiss
februari
seen
tenfold
increas
cumul
case
past
day
first
genom
publish
deposit
ncbi
databas
genbank
access
number
januari
allow
sever
laboratori
around
world
includ
laboratori
develop
nucleic
acid
amplif
test
naat
detect
genet
materi
current
mani
quantit
rtpcr
rtqpcr
base
naat
develop
target
variou
viral
gene
includ
nucleocapsid
n
polyprotein
spike
envelop
e
gene
region
posit
strand
kb
rna
viru
test
wide
use
screen
suspect
patient
return
travel
outbreak
area
close
contact
case
healthi
individu
may
asymptomat
carrier
viru
typic
respiratori
sampl
sputum
nasal
throat
nasopharyng
swab
collect
consecut
two
day
test
confirm
diagnosi
confirm
recoveri
diagnost
test
recogn
ratelimit
step
global
need
ramp
laboratori
capac
welldevelop
lowincom
countri
worsen
possibl
asymptomat
individu
commun
could
transmit
infect
henc
increas
need
screen
healthi
individu
mild
symptom
quantit
rtpcr
deploy
primari
method
detect
research
hospit
laboratori
account
singlemolecul
sensit
eas
assay
design
avail
reagent
howev
sever
technic
challeng
test
requir
rna
extract
follow
amplif
detect
current
stateofart
pcr
typic
requir
minut
rna
extract
minut
amplif
highli
train
technic
staff
costli
equip
cost
usd
facil
requir
factor
contribut
longer
turnaroundtim
cost
manpow
capit
consum
well
risk
carryov
contamin
biosafeti
risk
handl
clinic
sampl
limit
suppli
extract
reagent
test
kit
worldwid
addit
asymptomat
individu
also
led
presymptomat
transmiss
commun
increas
demand
laboratori
test
factor
motiv
us
explor
way
simplifi
shorten
protocol
without
signific
compromis
high
sensit
specif
rtqpcr
therefor
propos
novel
method
term
direct
rapid
extractionfre
pcr
directpcr
diagnosi
pcr
directli
crude
sampl
without
nucleic
acid
purif
attempt
use
inhibitorresist
enzym
modifi
buffer
addit
mastermix
group
sivalingam
et
al
unpublish
other
previous
detect
whole
dengu
viru
singl
tube
reaction
contain
serum
plasma
vv
direct
amplif
sampl
also
report
detect
rna
virus
includ
african
chikungunya
viru
norovirus
bovin
viral
diarrhea
viru
varieti
matric
includ
serum
throat
swab
faec
howev
presenc
pcr
inhibitor
mucin
protein
pose
challeng
direct
amplif
respiratori
sampl
limit
studi
amplifi
coronavirus
directli
specimen
develop
directpcr
protocol
use
wide
use
valid
pcr
primer
establish
analyt
perform
dna
rna
templat
respiratori
sampl
transfer
protocol
benchtop
portabl
thermocycl
sampl
control
use
assay
develop
biosafeti
purpos
synthet
nucleic
acid
rather
whole
viru
templat
use
develop
assay
posit
strand
rna
coronaviru
synthes
singl
strand
rna
ssrna
amplicon
sequenc
bp
nucleocapsid
n
gene
integr
dna
technolog
san
diego
plasmid
dna
contain
n
gene
merscov
sarscov
also
use
posit
control
ruo
plasmid
control
integr
dna
technolog
san
diego
ssrna
human
ribonucleas
p
rp
gene
amplicon
sequenc
bp
synthes
use
intern
control
integr
dna
technolog
san
diego
approxim
ml
sputum
nasal
exud
healthi
adult
research
team
member
collect
hypersalin
inhal
use
spikein
ssrna
plasmid
control
briefli
respiratori
sampl
mix
vv
ratio
sputasol
oxoid
england
vortex
minut
remov
viscos
allow
direct
addit
pcr
reaction
mix
primer
probe
target
n
gene
previous
publish
chines
center
diseas
control
prevent
beij
china
human
ribonucleas
p
rp
gene
primer
probe
previous
publish
us
center
diseas
control
prevent
cdc
protocol
ad
intern
control
detect
presenc
human
rna
sampl
oligonucleotid
primer
probe
commerci
purchas
integr
dna
technolog
san
diego
quantit
rtpcr
initi
perform
monoplex
singletub
reaction
mixtur
use
two
differ
separ
mastermix
standard
rtqpcr
pcr
master
mix
contain
invitrogen
iii
onestep
rtqpcr
kit
ribonucleas
inhibitor
life
technolog
usa
tenfold
dilut
rna
templat
duplic
ad
total
volum
dnasernasefre
water
use
nontempl
control
ntc
reaction
complet
plate
format
fast
optic
reaction
plate
barcod
ml
rtqpcr
assay
perform
follow
condit
revers
transcript
minut
initi
denatur
minut
cycl
denatur
second
anneal
second
use
standard
benchtop
realtim
thermocycl
steponeplu
realtim
pcr
system
appli
biosystem
usa
specimen
consid
posit
amplif
curv
cross
threshold
line
within
quantif
cycl
cq
sampl
use
spikein
experi
freshli
prepar
briefli
sputum
nasal
exud
sampl
mix
sputasol
aliquot
u
recombin
ribonucleas
inhibitor
life
technolog
usa
ad
aliquot
invert
mix
meantim
rna
templat
tenfold
serial
dilut
dnasernasefre
water
achiev
order
magnitud
next
dilut
rna
templat
spike
sputum
nasal
exud
mix
form
total
volum
subsequ
rna
spikedmatric
contain
sputum
nasal
exud
respect
directli
ad
reaction
volum
inhibitorresist
pcr
reaction
mix
contain
pcr
enhanc
inhibitorresist
enzym
direct
onestep
sp
rtqpcr
taqprob
kit
vitanavi
technolog
llc
usa
forward
revers
primer
fambas
probe
recombin
ribonucleas
inhibitor
life
technolog
usa
describ
rna
templat
dnasernasefre
water
use
posit
control
sputum
nasal
exud
sampl
contain
sputasol
also
ad
blank
nontempl
control
ntc
respect
matric
reaction
mixtur
incub
minut
denatur
minut
follow
cycl
denatur
second
anneal
second
standard
benchtop
realtim
thermocycl
steponeplu
realtim
pcr
system
appli
biosystem
usa
lowest
limit
detect
lod
determin
use
n
rna
templat
tenfold
serial
dilut
sputum
nasal
exud
sampl
lod
defin
last
dilut
quantif
cycl
cq
valu
could
detect
replic
linear
rang
correl
theoret
log
copi
number
calcul
concentr
molar
synthet
nucleic
acid
cq
valu
establish
appli
bestfit
line
data
linear
regress
analysi
pcr
effici
e
calcul
slope
linear
equat
directpcr
assay
modifi
order
reduc
turnaround
time
reagent
cost
final
reaction
volum
reduc
reduc
number
cycl
reduc
revers
transcript
rt
step
minut
minut
reduc
initi
denatur
minut
second
reduc
anneal
durat
second
second
tenfold
serial
dilut
rna
spikein
matric
describ
use
duplic
evalu
modifi
assay
determin
fast
protocol
detect
briefli
aliquot
templat
ad
pcr
reaction
mix
mention
similarli
plasmid
control
n
gene
merscov
sarscov
tenfold
serial
dilut
dnasernasefre
water
achiev
order
magnitud
respect
subsequ
dilut
plasmid
templat
spike
sputum
nasal
exud
mix
contain
sputasol
rnaseout
form
total
volum
describ
intern
control
use
human
ribonucleas
p
rp
gene
evalu
directpcr
human
rp
sputum
nasal
exud
use
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
assay
describ
serial
dilut
human
rp
rna
templat
water
use
posit
control
merscov
sarscov
plasmid
control
ad
neg
control
amplif
perform
standard
benchtop
realtim
thermocycl
steponeplu
realtim
pcr
system
appli
biosystem
usa
detail
protocol
directpcr
avail
supplementari
inform
supplementari
directpcr
assay
valid
portabl
thermocycl
mygo
mini
iti
life
scienc
ltd
ireland
use
monoplex
singletub
protocol
describ
portabl
thermocycl
lightweight
less
kg
dimens
cm
width
cm
depth
cm
height
perform
reaction
use
standard
ml
clear
qpcr
tube
reaction
volum
perform
portabl
qpcr
thermocycl
evalu
compar
lod
amplif
effici
e
directpcr
assay
limit
detect
lod
determin
plot
quantif
cycl
cq
copi
number
concentr
correl
coeffici
r
calcul
linear
regress
analysi
amplif
effici
e
calcul
slope
loglinear
curv
use
given
equat
e
slope
intercept
linear
regress
line
test
statist
signific
use
analysi
covari
ancova
graphpad
prism
repeat
reproduc
rtqpcr
assay
determin
analys
mean
valu
standard
deviat
cq
valu
use
synthet
rna
templat
n
gene
target
lod
standard
rtqpcr
assess
rna
copi
per
reaction
cq
mean
valu
howev
amplif
observ
rna
spike
sputum
nasal
exud
use
standard
mastermix
use
pcr
inhibitorresist
mastermix
lod
directpcr
determin
rna
copi
per
reaction
cq
mean
valu
th
order
magnitud
tabl
lowest
cq
observ
correspond
x
rna
copi
per
reaction
fig
directpcr
assay
complet
minut
benchtop
thermocycl
control
assay
amplif
effici
e
correl
coeffici
r
fig
amplif
observ
ntc
next
directpcr
assay
evalu
use
rna
spike
sputum
nasal
exud
matric
amplif
spike
rna
pcr
inhibit
toler
observ
concentr
sputum
nasal
exud
vv
pcr
reaction
rna
spike
sputum
sampl
sensit
greater
control
rna
copi
per
reaction
cq
tabl
lowest
cq
observ
correspond
x
rna
copi
per
reaction
fig
rna
spike
nasal
exud
found
lod
rna
copi
per
reaction
cq
tabl
lod
achiev
one
two
duplic
test
lowest
cq
nasal
exud
observ
correspond
x
rna
copi
per
reaction
fig
pcr
effici
reveal
lower
amplif
effici
e
spike
sputum
nasal
exud
compar
control
correl
coeffici
r
sputum
nasal
exud
respect
linear
regress
line
similar
slope
pvalu
intercept
significantli
differ
pvalu
fig
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
reduc
durat
cost
directpcr
assay
modifi
total
reaction
volum
durat
cycl
condit
addit
templat
amplif
rna
templat
use
fast
directpcr
demonstr
detect
rna
copi
per
reaction
cq
contrast
rna
copi
per
reaction
cq
detect
directpcr
assay
fast
directpcr
complet
minut
compar
minut
directpcr
assay
lod
similar
cq
rna
copi
per
reaction
cq
spike
sputum
nasal
exud
sampl
respect
tabl
use
posit
control
plasmid
encod
n
gene
lod
found
copi
per
reaction
cq
use
benchtop
thermocycl
lod
copi
per
reaction
observ
plasmid
spike
sputum
nasal
exud
sampl
cq
cq
mean
respect
four
order
magnitud
fig
amplif
observ
neg
control
use
merscov
sarscov
plasmid
human
rp
primer
use
intern
control
amplifi
detect
presenc
human
rna
present
crude
sampl
data
shown
use
crude
sputum
nasal
exud
directli
mean
cq
valu
human
rp
respect
benchtop
thermocycl
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
commerci
avail
portabl
qpcr
thermocycl
valid
compar
benchtop
thermocycl
use
fast
directpcr
assay
rna
plasmid
templat
spike
sputum
nasal
exud
amplif
effici
rna
control
show
signific
differ
pvalu
benchtop
portabl
thermocycl
thermocycl
similar
lod
rna
copi
per
reaction
use
rna
spikein
sputum
portabl
thermocycl
lod
rna
copi
per
reaction
cq
compar
rna
copi
per
reaction
use
benchtop
thermocycl
tabl
hand
thermocycl
lod
rna
copi
per
reaction
use
rna
spikein
nasal
exud
tabl
use
plasmid
control
signific
differ
pvalu
amplif
effici
thermocycl
fig
next
use
plasmid
encod
n
gene
control
lod
found
copi
per
reaction
use
plasmid
templat
plasmid
spikein
sputum
benchtop
portabl
thermocycl
respect
thermocycl
similar
sensit
copi
per
reaction
use
plasmid
spikein
nasal
exud
tabl
term
durat
reaction
took
minut
portabl
thermocycl
minut
benchtop
thermocycl
quantit
rtpcr
rna
current
method
choic
diagnosi
directpcr
method
use
inhibitorresist
enzym
reagent
elimin
rna
extract
step
use
synthet
rna
templat
obviat
need
handl
viral
nucleic
acid
fast
directpcr
protocol
achiev
reduct
assay
time
optim
thermocycl
condit
also
valid
analyt
perform
directpcr
spike
crude
sampl
demonstr
use
portabl
platform
current
rtqpcr
involv
rna
purif
part
prepcr
sampl
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
prepar
procedur
least
four
six
hour
need
timetoresult
laboratori
cycl
condit
optim
fast
directpcr
small
reaction
volum
shorter
rt
anneal
durat
abl
amplifi
less
hour
fig
furthermor
cost
save
nucleic
acid
extract
kit
avail
reagent
may
limit
laboratori
capac
ramp
demand
increas
global
moreov
directpcr
singletub
homogen
reaction
reduc
handson
time
biosafeti
risk
laboratori
personnel
well
likelihood
carryov
contamin
one
caveat
howev
fast
directpcr
sampl
low
viral
load
sampl
error
sinc
sampl
use
nucleic
acid
extract
hand
serv
concentr
rna
typic
sampl
volum
although
yield
also
low
variabl
henc
sampl
expect
low
count
near
limit
detect
directpcr
larger
volum
reaction
includ
higher
templat
volum
may
necessari
reduc
risk
fals
neg
reduct
amplif
effici
common
concern
directpcr
crude
sampl
eg
respiratori
sampl
blood
serum
presenc
pcr
inhibitor
decreas
sensit
accuraci
pathogen
detect
interf
polymeras
activ
degrad
nucleic
acid
effici
cell
lysi
varieti
method
develop
overcom
inhibit
includ
inhibitor
toler
polymeras
addit
buffer
modif
studi
use
one
commerci
avail
formul
toler
pcr
inhibit
sputum
nasal
exud
well
bloodserumurin
data
shown
unlik
formul
could
use
well
studi
amplif
directli
sputum
nasal
exud
reduc
effici
pcr
compar
water
control
net
effect
threshold
detect
nasopharyng
swab
sputum
suggest
effect
clinic
sampl
diagnosi
assess
direct
pcr
use
matric
feasibl
extend
common
sampl
use
covid
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
test
swab
throat
endotrach
tube
bronchoalveolar
lavag
fluid
focus
directpcr
protocol
commonli
use
primerprob
set
develop
china
cdc
us
cdc
target
n
gene
well
gene
internet
control
rp
data
shown
expect
direct
pcr
similarli
use
viral
primer
target
pcr
amplicon
develop
well
multiplex
amplif
sever
target
tube
nevertheless
may
inhibitor
pcr
present
sampl
test
clinic
valid
larger
seri
need
exclud
possibl
quantit
viral
nucleic
acid
sampl
rtqpcr
use
studi
correl
viral
load
sever
prognosi
transmiss
cq
valu
patient
sampl
rang
late
cycl
close
cours
infect
nasal
viral
load
shown
peak
within
day
symptom
onset
accord
small
studi
throat
nasal
swab
patient
use
rna
templat
directpcr
assay
dynam
rang
order
magnitud
mean
cq
rang
indic
reproduc
quantit
wide
rang
includ
high
viral
titer
method
could
use
futur
studi
assess
viral
surviv
decontamin
method
prevent
intervent
observ
even
spike
water
sampl
amplif
effici
cq
valu
obtain
limit
detect
depend
factor
reagent
mastermix
model
thermocycl
reaction
volum
cycl
protocol
use
tabl
variabl
would
even
signific
clinic
set
ad
confound
factor
type
sampl
sampl
method
dilut
transport
buffer
durat
condit
storag
reagent
protocol
rna
extract
difficult
standard
across
healthcar
set
laboratori
remov
rna
extract
step
could
help
reduc
variabl
rna
yield
qualiti
variabl
sampl
type
sampl
procedur
still
render
entir
assay
nonquantit
henc
caution
overinterpret
cq
valu
especi
absenc
inhous
qualiti
control
calibr
data
combin
protocol
reagent
thermocycl
technic
factor
may
also
partli
explain
fals
neg
tempor
variabl
viral
rna
shed
report
variou
studi
use
fix
criteria
cq
posit
cq
inconclus
repeat
test
cq
neg
fact
data
demonstr
viral
rna
concentr
approach
threshold
detect
assay
lod
cq
mean
valu
may
exceed
tabl
sinc
neg
control
probebas
assay
remain
consist
neg
possibl
report
cq
posit
henc
achiev
better
standard
quantit
result
propos
instead
report
cq
laboratori
may
report
equival
viral
copi
number
per
unit
sampl
volum
deriv
run
serial
dilut
viral
rna
control
inhous
directpcr
assay
demonstr
commerci
avail
portabl
thermocycl
weigh
less
kg
potenti
allow
pcr
perform
outsid
molecular
biolog
laboratori
mobil
laboratori
low
resourc
set
mani
realtim
fieldabl
thermocycl
avail
smaller
portabl
less
costli
benchtop
one
three
evalu
perform
similar
benchtop
one
data
shown
optic
detect
modul
fluoresc
sensit
vari
design
overal
sensit
assay
similar
type
thermocycl
test
tabl
thermocycl
paramet
could
also
optim
rapid
fig
need
transport
sampl
central
laboratori
could
prolong
avail
test
result
beyond
hour
use
portabl
thermocycl
coupl
appropri
train
qualiti
control
procedur
could
allow
use
rtqpcr
nearer
patient
primari
healthcar
set
rapid
pointofcar
poc
test
use
commun
level
identifi
expert
group
key
research
prioriti
need
transport
sampl
central
laboratori
could
prolong
avail
test
result
beyond
hour
use
portabl
thermocycl
coupl
appropri
train
qualiti
control
procedur
could
allow
use
rtqpcr
nearer
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
patient
primari
healthcar
set
though
unlik
directpcr
would
complet
replac
convent
rna
extract
rtqpcr
larg
laboratori
confirmatori
diagnosi
tradeoff
reliabl
portabl
eas
use
costeffect
could
use
patient
screen
public
health
surveil
set
limit
laboratori
resourc
facil
directpcr
could
address
specif
requir
challeng
deliv
molecular
genet
test
poc
set
poc
diagnost
could
play
import
role
detect
diagnosi
control
pandem
time
diagnosi
primari
healthcar
facil
complement
realtim
fever
surveil
screen
sever
technolog
propos
use
enabl
molecular
test
poc
includ
isotherm
amplif
method
requir
thermocycl
like
loopmedi
isotherm
amplif
lamp
howev
given
widespread
valid
exist
pcr
primerprob
set
well
like
need
modifi
amplif
primer
probe
viral
sequenc
evolv
futur
argu
perform
pcr
use
directpcr
method
gener
adapt
approach
direct
amplif
viral
rna
sampl
without
rna
purif
develop
reduc
handsontim
timetoresult
cost
viral
lysi
revers
transcript
amplif
detect
achiev
singletub
homogen
reaction
take
less
hour
perform
portabl
thermocycl
analyt
valid
perform
sputum
nasal
exud
directpcr
assay
high
sensit
rna
copi
per
reaction
quantit
dynam
rang
order
magnitud
method
may
use
current
global
pandem
situat
resourc
constrain
time
result
need
